OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/26/2025
Back to search
Official data from USPTO
ORBICULE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
1, 5, 42
Filing date
07/04/2023
Registration date
09/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/24/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
CN
Examiner
SMITH, REBECCA A
Law office
M10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "ORBICULE".
Holders and representatives
Holders
ARGORNA PHARMACEUTICALS CO., LTD
Representatives
Victoria Friedman Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Test paperchemical; chemical preparations in the nature of filtering materials for use in the manufacture of pharmaceuticals; chemical getters; acid proof chemical compositions for use in the manufacture of pharmaceuticals; antioxidants for use in the manufacture of pharmaceuticals; chemical reagentsother than for medical or veterinary purposes; chemical accelerants; chemical preparations for scientific purposesother than for medical or veterinary use; biochemicals for scientific use; biochemical catalysts
Class 5
Pharmaceutical preparations for the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; chemical preparations for medical purposesfor the treatment of tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; antimicrobials for dermatologic use; nutritive substances for micro-organisms for medical use; sterilizing preparations; medicinal infusions for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for treating tumorsasthmaarthritisviral diseasesrespiratory diseasesinflammationfibrosishypertensionhyperlipidemiacardiovascular diseaseseye diseasesanginadiabetesinsomnia; chemical reagents for medical or veterinary purposes
Class 42
Chemical analysis; scientific laboratory services; chemical research; inspection of drugs for quality control purposes; biomedical research services; development of pharmaceutical preparations and pharmaceuticals; research and development services in the field of chemistry; pharmaceutical research
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/22/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/04/2025
FIMP
FINAL DISPOSITION PROCESSED
03/04/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/24/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2024
RFNT
REFUSAL PROCESSED BY IB
04/24/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/02/2024
RFRR
REFUSAL PROCESSED BY MPU
04/02/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/18/2024
CNRT
NON-FINAL ACTION WRITTEN
03/17/2024
DOCK
ASSIGNED TO EXAMINER
03/16/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2024
Continuous trademark protection
Get notified about every new filing that threatens ORBICULE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.